The Ministry of Food and Drug Safety (MFDS), which is organizing a symposium on artificial intelligence (AI)-based medical products jointly with the U.S. Food and Drug Administration (FDA), has launched a preparatory planning team.
The ministry said Friday that it is launching the AIRIS 2024 Preparatory Planning Team to successfully host the “AI Regulatory and International Symposium 2024 (AIRIS 2024),” which will be co-hosted by Korea and the U.S. Vice Minister of Food and Drug Safety Kim Yoo-mi will lead the preparatory planning team.
MFDS has been promoting the symposium since April last year when President Yoon Suk Yeol visited the U.S. and formed the Korea-U.S. Alliance for Advanced Science and Technology.
AIRIS 2024 is an international event where Korean and U.S. medical product regulators invite their counterparts worldwide to Seoul from Feb. 26-29.
The ministry said it is meaningful that Korea, which the international community has recognized for its capabilities in regulating medical products using AI technology, will lead the global regulatory arrangements.
The symposium will be attended by domestic and international industry and academia to discuss various topics ranging from the development trends of medical products using AI to prospects and global regulatory directions.
The AIRIS 2024 Preparatory Planning Team will go all out to promote Korea's excellent regulatory capabilities to the world through the symposium by planning and operating the event program, inviting domestic and foreign guests, and conducting domestic and international public relations activities, according to the ministry.
The event outline, detailed program information, and registration process are on the official website at https://airis2024.org.
In addition, the ministry is continuously promoting technical cooperation with the U.S. FDA as part of the Korea-U.S. Alliance for Advanced Science and Technology to lead global regulation of high-tech innovations, including AI medical products. Since June, for instance, it has been preparing to hold an international symposium involving world regulators and conducting practical discussions to lead global regulation.
"We expect the symposium to serve as a springboard for Korea to become a global center for bio-digital health based on the strong Korea-US high-tech alliance," the ministry said. "We will continue to do our best to lead international standards in medical products with advanced technologies."